Phosphatase inhibition in human neuroblastoma cells alters tau antigenicity and renders it incompetent to associate with exogenous microtubules

FEBS Letters
T B Shea, I Fischer

Abstract

The abnormal cytoskeletal organization observed in Alzheimer's disease has been suggested to arise from hyperphosphorylation of tau and the resultant elimination of its ability to associate with microtubules. This possibility has been supported by a number of studies under cell-free conditions utilizing various kinases, phosphatases and their corresponding inhibitors each, and by treatment of intact cells with kinase and phosphatase activators and inhibitors. However, in studies utilizing intact cells, it remained difficult to attribute microtubule compromise specifically to tau hyperphosphorylation due to potential influence of inhibitors on tubulin and/or other microtubule-associated proteins which themselves possess assembly-regulatory phosphorylation sites. To address this difficulty, we subjected SH-SY-5Y human neuroblastoma cells to treatment with the phosphatase inhibitor okadaic acid (OA), which has been previously demonstrated to depolymerize microtubules in these cells. OA induced an increase in tau hyperphosphorylation as evidenced by an increase in Alz-50 immunoreactivity and a corresponding decrease in Tau-1 immunoreactivity. When tau-enriched fractions from OA-treated cells were incubated under microtubule assembl...Continue Reading

References

Jul 15, 1992·Biochemical and Biophysical Research Communications·M G SacherW E Mushynski
Sep 1, 1992·Neurobiology of Aging·P Davies
Oct 1, 1987·Annals of Neurology·B Wolozin, P Davies
Oct 1, 1985·The Journal of Cell Biology·L I BinderL I Rebhun
Jan 1, 1994·Neurobiology of Aging·E M Mandelkow, E Mandelkow
Feb 20, 1995·FEBS Letters·T TanakaI Grundke-Iqbal
Mar 3, 1995·The Journal of Biological Chemistry·J Z WangK Iqbal
Mar 15, 1994·Biochemistry·A VandecandelaereP M Bayley
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·A C AlonsoK Iqbal
Sep 1, 1993·Journal of Neurochemistry·C X GongK Iqbal
Jan 1, 1993·Annals of Neurology·K A HarrisM L Billingsley
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·M GoedertV M Lee

❮ Previous
Next ❯

Citations

Nov 1, 2000·Cell Motility and the Cytoskeleton·H Ksiezak-RedingD W Dickson
Oct 16, 2003·Brain Research. Molecular Brain Research·Fatma J EkinciThomas B Shea
Dec 24, 1997·Neuroscience Letters·D UbertiM Memo
Nov 28, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Emmanuel PlanelKaren E Duff
Jun 27, 2009·Neuroscience·S BaigS Love
Nov 20, 2012·Brain Research·Sangmook Lee, Thomas B Shea
Jul 4, 2002·The Journal of Biological Chemistry·Ann-Kristin Ruud LarsenPer O Seglen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.